{"id":"https://openalex.org/W2979814693","doi":"https://doi.org/10.1182/blood.v124.21.645.645","title":"Serine/Threonine Kinase STK4 Is a Novel Target in Myeloma","display_name":"Serine/Threonine Kinase STK4 Is a Novel Target in Myeloma","publication_year":2014,"publication_date":"2014-12-06","ids":{"openalex":"https://openalex.org/W2979814693","doi":"https://doi.org/10.1182/blood.v124.21.645.645","mag":"2979814693"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v124.21.645.645","doi":"https://doi.org/10.1182/blood.v124.21.645.645","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.645.645","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034020009","display_name":"Francesca Cottini","orcid":"https://orcid.org/0000-0001-8676-7840","observed_orcids":["https://orcid.org/0000-0001-8676-7840"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francesca Cottini","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091207345","display_name":"Teru Hideshima","orcid":"https://orcid.org/0000-0003-2939-6224","observed_orcids":["https://orcid.org/0000-0003-2939-6224"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Teru Hideshima","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074563113","display_name":"Sara J. Buhrlage","orcid":"https://orcid.org/0000-0003-4562-1823","observed_orcids":["https://orcid.org/0000-0003-4562-1823"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sara Buhrlage","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022352605","display_name":"Nathanael S. Gray","orcid":"https://orcid.org/0000-0001-5354-7403","observed_orcids":["https://orcid.org/0000-0001-5354-7403"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nathanael S. Gray","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043526996","display_name":"Paul Gerard Guy Richardson","orcid":"https://orcid.org/0000-0002-7426-8865","observed_orcids":["https://orcid.org/0000-0002-7426-8865"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul G. Richardson","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050323670","display_name":"Giovanni Tonon","orcid":"https://orcid.org/0000-0003-2973-5038","observed_orcids":["https://orcid.org/0000-0003-2973-5038"]},"institutions":[{"id":"https://openalex.org/I4210133214","display_name":"IRCCS Ospedale San Raffaele","ror":"https://ror.org/039zxt351","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210133214","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giovanni Tonon","raw_affiliation_strings":["San Raffaele Scientific Institute, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Raffaele Scientific Institute, Milan, Italy","institution_ids":["https://openalex.org/I4210133214"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth C Anderson","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5022352605","https://openalex.org/A5074563113"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.29564965,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"124","issue":"21","first_page":"645","last_page":"645"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12065","display_name":"Hippo pathway signaling and YAP/TAZ","score":0.5454000234603882,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12065","display_name":"Hippo pathway signaling and YAP/TAZ","score":0.5454000234603882,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.42800000309944153,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mst1","display_name":"MST1","score":0.8349999785423279},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9259999990463257},{"id":"https://openalex.org/keywords/yap","display_name":"YAP","score":0.9670000076293945},{"id":"https://openalex.org/keywords/hippo-signaling-pathway","display_name":"Hippo signaling pathway","score":0.8889999985694885},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.9169999957084656},{"id":"https://openalex.org/keywords/p73","display_name":"p73","score":0.9340000152587891},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8650000095367432},{"id":"https://openalex.org/keywords/kinase-screening","display_name":"kinase screening","score":0.5529999732971191},{"id":"https://openalex.org/keywords/drug-target-identification","display_name":"drug target identification","score":0.44600000977516174},{"id":"https://openalex.org/keywords/plasma-cell-proliferation","display_name":"plasma cell proliferation","score":0.4950000047683716},{"id":"https://openalex.org/keywords/bax","display_name":"Bax","score":0.3479999899864197},{"id":"https://openalex.org/keywords/puma","display_name":"PUMA","score":0.9549999833106995},{"id":"https://openalex.org/keywords/p21","display_name":"p21","score":0.8130000233650208}],"concepts":[{"id":"https://openalex.org/C2780219982","wikidata":"https://www.wikidata.org/wiki/Q17544238","display_name":"YAP1","level":4,"score":0.8182474374771118},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.6397277116775513},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5568780303001404},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.5510811805725098},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.49858665466308594},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4922131597995758},{"id":"https://openalex.org/C119056186","wikidata":"https://www.wikidata.org/wiki/Q1431332","display_name":"Gene silencing","level":3,"score":0.48646876215934753},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.47651588916778564},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.47418317198753357},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4722185432910919},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.45896458625793457},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.4407249987125397},{"id":"https://openalex.org/C172512520","wikidata":"https://www.wikidata.org/wiki/Q5768379","display_name":"Hippo signaling pathway","level":3,"score":0.42210352420806885},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.41086500883102417},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.16894689202308655},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1529507040977478},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.13318052887916565},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.10127705335617065}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v124.21.645.645","doi":"https://doi.org/10.1182/blood.v124.21.645.645","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.645.645","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7217481438","https://openalex.org/W2559643922","https://openalex.org/W4252794482","https://openalex.org/W2162730852","https://openalex.org/W2604894069","https://openalex.org/W2561427351","https://openalex.org/W4234943558","https://openalex.org/W3177143471","https://openalex.org/W2471123721","https://openalex.org/W2609150367"],"abstract_inverted_index":{"Abstract":[0],"Multiple":[1],"myeloma":[2],"(MM)":[3],"is":[4,161,179,483],"a":[5,15,76,241,278,391,412,484,501],"disease":[6],"characterized":[7],"by":[8,81,90,182,264,432],"clonal":[9],"proliferation":[10],"of":[11,27,33,43,56,64,79,87,94,128,140,165,185,227,239,243,252,297,306,332,366,377,398,430,476,504,512],"plasma":[12],"cells":[13,24,65,73,311,337,454,463],"with":[14,66,115,223,249,294,340,410,455,506],"complex":[16],"genomic":[17,283],"phenotype.":[18],"We":[19,174],"recently":[20],"demonstrated":[21],"that":[22,159,176,415],"MM":[23,72,156,200,244,274,369,443,490],"have":[25],"signs":[26],"ongoing":[28,361],"DNA":[29,34,69,129,171],"damage":[30,35],"and":[31,40,99,107,133,147,207,216,303,309,317,344,355,371,400,421,435,447,486,492],"activation":[32,55,139,184,331],"response,":[36],"via":[37],"ATM":[38],"phosphorylation":[39],"nuclear":[41],"localization":[42],"ABL1":[44],"(Cottini":[45],"et":[46],"al,":[47],"Nature":[48],"Medicine,":[49],"2014).":[50],"In":[51,125],"normal":[52],"cells,":[53,157,275],"the":[54,62,126,138,162,183,186,237,253,330,375,380,458],"ATM/ABL1":[57],"pathway":[58,188],"eventually":[59],"results":[60],"in":[61,84,102,112,155,204,205,208,325,335,353,368,379,390,408,418,428,439,452,460,489,500],"death":[63,101,202],"terminal":[67],"unrepaired":[68],"damage.":[70],"However,":[71,457],"inactivate":[74],"YAP1,":[75],"downstream":[77],"target":[78,488],"ABL1,":[80],"homozygous":[82,279],"deletions":[83],"10":[85],"percent":[86,302,305],"patients":[88,505],"or":[89,406,472],"protein/mRNA":[91],"downregulation.":[92],"Re-expression":[93],"YAP1":[95,103,117,131,160,168,177,195,282,333,351],"induces":[96],"growth":[97,232,259,370],"inhibition":[98],"cell":[100,113,201,245,444],"deleted-cell":[104],"lines":[105,114,246,445],"(KMS-18":[106],"KMS-20),":[108],"as":[109,111,144,287,449,451],"well":[110,450],"low":[116,154,167],"expression":[118,178,196],"(MM.1S),":[119],"according":[120],"to":[121,135,362,372,514],"an":[122],"ABL1-dependent":[123],"mechanism.":[124],"presence":[127],"damage,":[130],"stabilizes":[132],"binds":[134],"TP73,":[136,389],"facilitating":[137],"TP73-target":[141],"genes,":[142],"such":[143],"BAX,":[145],"PUMA,":[146],"CDKN1A":[148],"(p21).":[149],"TP73":[150,399,434],"levels":[151],"are":[152,218,360],"generally":[153],"indicating":[158],"main":[163],"regulator":[164],"TP73;":[166],"therefore":[169],"blocks":[170],"damage-mediated":[172],"apoptosis.":[173,272],"identified":[175],"tightly":[180],"regulated":[181],"Hippo":[187],"serine/threonine":[189],"kinase":[190,212],"STK4.":[191],"Upon":[192],"STK4":[193,367,385,404,482,493],"silencing,":[194],"was":[197,214,247,437],"increased,":[198],"causing":[199],"both":[203,419],"vitro":[206],"vivo":[209],"settings.":[210],"A":[211,425],"screening":[213],"performed":[215],"we":[217,402],"currently":[219],"optimizing":[220],"different":[221],"compounds":[222],"anti-STK4":[224],"activity.":[225],"One":[226],"them":[228],"(STK4i)":[229],"showed":[230],"promising":[231],"inhibitory":[233,260],"effects.":[234],"To":[235,328,394,480],"characterize":[236,374],"efficacy":[238],"STK4i,":[240,298],"panel":[242],"incubated":[248],"increasing":[250],"doses":[251],"compound":[254],"ranging":[255],"from":[256],"0.1-10":[257],"\u03bcM;":[258],"effects":[261,322,397],"were":[262,285,312,323,338],"measured":[263],"MTT":[265],"assay,":[266],"while":[267,320],"Annexin":[268,315],"V-PI":[269],"staining":[270],"detected":[271],"KSM-20":[273],"which":[276,349],"bear":[277],"deletion":[280],"for":[281,314,342],"locus,":[284],"used":[286,403],"negative":[288,474],"control.":[289],"After":[290],"48":[291],"hour":[292],"treatment":[293],"1\u03bcM":[295],"dose":[296],"62":[299],"percent,":[300],"66":[301],"15":[304],"MM.1S,":[307],"H929":[308,356],"U266":[310],"positive":[313],"V":[316],"PI":[318],"markers,":[319],"minimal":[321],"observed":[324,438],"KMS-20":[326],"cells.":[327,357,424],"test":[329],"axis":[334],"MM,":[336],"treated":[339],"STK4i":[341,378,407],"48hrs,":[343],"western":[345],"blot":[346],"analysis":[347],"followed,":[348],"confirmed":[350],"upregulation":[352],"MM.1S":[354],"Further":[358],"studies":[359],"evaluate":[363],"additional":[364],"functions":[365],"better":[373],"activity":[376,475],"bone":[381],"marrow":[382],"microenvironment.":[383],"Importantly,":[384],"silencing":[386,405],"also":[387],"upregulates":[388],"YAP1-dependent":[392],"manner.":[393],"investigate":[395],"synergic":[396],"TP53,":[401,417],"combination":[409],"Nutlin-3a,":[411],"MDM2":[413],"inhibitor":[414],"activates":[416],"wild-type":[420],"mutant":[422],"TP53":[423,436,440,470],"cooperative":[426],"response":[427,459],"terms":[429],"toxicity":[431],"combined":[433],"wild":[441],"type":[442],"(MM.1S":[446],"H929)":[448],"OPM-2":[453],"mutant-TP53.":[456],"mutant-TP53":[461,477],"patient":[462],"may":[464,495],"be":[465],"variable,":[466],"depending":[467],"on":[468,478],"residual":[469],"function":[471],"dominant":[473],"TP73.":[479],"conclude,":[481],"new":[485],"important":[487],"pathogenesis":[491],"inhibitors":[494],"represent":[496],"novel":[497],"therapeutic":[498],"options":[499],"broad":[502],"subset":[503],"MM.":[507],"Disclosures":[508],"No":[509],"relevant":[510],"conflicts":[511],"interest":[513],"declare.":[515]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2019-10-18T00:00:00"}